NEXUS AG header image

NEXUS AG

NXU

Equity

ISIN DE0005220909 / Valor 1099292

Xetra (2024-09-18)
EUR 53.10%

NEXUS AG
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

NEXUS AG is a European company specializing in the development of innovative software solutions for the healthcare sector. Their product offerings include a clinical information system (NEXUS / KIS) and integrated diagnostic modules (NEXUS / DIS), designed to meet the wide-ranging functional requirements of hospitals, psychiatric institutions, rehabilitation, and diagnostic centers. The company focuses on creating user-friendly process support tools that enhance efficiency and safety in patient care. With over 250,000 daily users, including doctors, nurses, and administrative staff across various healthcare facilities, NEXUS AG emphasizes close customer relationships and localized support. Employing approximately 1,700 staff members, the company operates in seven European countries and serves clients in an additional 23 countries through certified dealers. NEXUS AG's growth is evidenced by its expanding customer base and consistently increasing revenues and profits.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (07.08.2024):

Sales Growth

NEXUS AG reported a significant increase in sales for the first quarter of 2024, with sales rising by 14.5% from KEUR 55,020 to KEUR 62,988. This growth continues the positive trend observed in previous years.

EBITDA Improvement

The company's earnings before interest, taxes, depreciation, and amortization (EBITDA) saw a notable improvement, increasing by 11.7% to KEUR 12,953 in Q1 2024, compared to KEUR 11,602 in the same period of the previous year.

EBIT Increase

NEXUS AG's earnings before interest and taxes (EBIT) rose by 8.9% in the first quarter of 2024, reaching KEUR 8,373, up from KEUR 7,688 in Q1 2023. This reflects the company's strong operational performance.

Consolidated Surplus

The consolidated surplus for NEXUS AG increased sharply by 18.4% to KEUR 6,695 in Q1 2024, compared to KEUR 5,654 in the same quarter of the previous year, indicating robust profitability.

Cash Resources

As of March 31, 2024, NEXUS AG had cash resources amounting to KEUR 117,219, up from KEUR 97,434 at the end of 2023. This strong cash position underscores the company's financial stability and liquidity.

Summarized from source with an LLMView Source

Key figures

3.51%1Y
-30.6%3Y
74.7%5Y

Performance

27.6%1Y
35.3%3Y
36.9%5Y

Volatility

Market cap

937 M

Market cap (USD)

Daily traded volume (Shares)

5,464

Daily traded volume (Shares)

1 day high/low

53.9 / 52

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Kudelski SA
Kudelski SA Kudelski SA Valor: 1226836
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.11%CHF 1.45
Crealogix Holding AG
Crealogix Holding AG Crealogix Holding AG Valor: 1111570
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 59.00
Kuros Biosciences Ltd
Kuros Biosciences Ltd Kuros Biosciences Ltd Valor: 32581411
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.32%CHF 19.98
ASMALLWORLD Ltd
ASMALLWORLD Ltd ASMALLWORLD Ltd Valor: 40488012
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%CHF 1.42
Melexis NV
Melexis NV Melexis NV Valor: 723330
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%EUR 76.45
Genmab A/S
Genmab A/S Genmab A/S Valor: 1129757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.87%DKK 1,759.50
Samsung SDI JH
Samsung SDI JH Samsung SDI JH Valor: 1073444
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.65%EUR 61.60
Nemetschek SE
Nemetschek SE Nemetschek SE Valor: 110055293
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.20%EUR 16.50
Hyrican Informationssysteme AG
Hyrican Informationssysteme AG Hyrican Informationssysteme AG Valor: 1094755
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 5.15
Turbon AG
Turbon AG Turbon AG Valor: 350812
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.64%EUR 3.14